肺癌筛查——用于肺癌筛查的低剂量CT：近期试验结果及后续步骤
Lung cancer screening-low dose CT for lung cancer screening: recent trial results and next steps.
作者信息
O'Dowd Emma Louise, Baldwin David R
机构信息
Department of Respiratory Medicine, Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, UK.
出版信息
Br J Radiol. 2018 Oct;91(1090):20170460. doi: 10.1259/bjr.20170460. Epub 2017 Oct 17.
Abstract
Screening for lung cancer using low-dose CT has already been implemented in North America following the results of the National Lung Screening Trial. Outside North America, clinicians and researchers are addressing issues that may have a major impact on the success of screening programmes by reviewing results of existing trials and by designing new research and pilot programmes. This review summarizes the work that has been done to try to answer the remaining questions and highlights potential barriers which may affect screening uptake and cost-effectiveness.
摘要
根据国家肺癌筛查试验的结果，低剂量CT肺癌筛查已在北美实施。在北美以外地区，临床医生和研究人员正在通过回顾现有试验结果以及设计新的研究和试点项目，来解决可能对筛查项目的成功产生重大影响的问题。本综述总结了为试图回答剩余问题所做的工作，并强调了可能影响筛查接受度和成本效益的潜在障碍。
相似文献
1
Lung cancer screening-low dose CT for lung cancer screening: recent trial results and next steps.
Br J Radiol. 2018 Oct;91(1090):20170460. doi: 10.1259/bjr.20170460. Epub 2017 Oct 17.
2
European and North American lung cancer screening experience and implications for pulmonary nodule management.
Eur Radiol. 2011 Dec;21(12):2445-54. doi: 10.1007/s00330-011-2219-y. Epub 2011 Aug 10.
3
The rationale for, and design of, a lung cancer screening program.
Cleve Clin J Med. 2012 May;79(5):337-45. doi: 10.3949/ccjm.79a.12018.
4
Early detection of lung cancer using ultra-low-dose computed tomography in coronary CT angiography scans among patients with suspected coronary heart disease.
Lung Cancer. 2017 Dec;114:1-5. doi: 10.1016/j.lungcan.2017.10.004. Epub 2017 Oct 9.
5
Long-term cancer risk associated with lung nodules observed on low-dose screening CT scans.
Lung Cancer. 2020 Jan;139:179-184. doi: 10.1016/j.lungcan.2019.11.017. Epub 2019 Nov 23.
6
Computed tomography screening for lung cancer.
Ann Thorac Surg. 2008 Feb;85(2):S699-700. doi: 10.1016/j.athoracsur.2007.09.054.
7
Lung cancer screening implementation: Complexities and priorities.
Respirology. 2020 Nov;25 Suppl 2:5-23. doi: 10.1111/resp.13963.
8
Nodule size and overdiagnosis in lung cancer CT screening.
J Natl Cancer Inst. 2014 Oct 18;106(11). doi: 10.1093/jnci/dju325. Print 2014 Nov.
9
A practical and adaptive approach to lung cancer screening: a review of international evidence and position on CT lung cancer screening in the Singaporean population by the College of Radiologists Singapore.
Singapore Med J. 2019 Nov;60(11):554-559. doi: 10.11622/smedj.2019145.
10
Accuracy of Models to Identify Lung Nodule Cancer Risk in the National Lung Screening Trial.
Am J Respir Crit Care Med. 2018 May 1;197(9):1220-1223. doi: 10.1164/rccm.201708-1632LE.
引用本文的文献
1
CXCL4L1 May Help Differentiate Benign from Malignant Pulmonary Lesions and Predicts Prognosis of Patients with Lung Cancer.
Cancer Manag Res. 2022 Jun 7;14:1903-1910. doi: 10.2147/CMAR.S352217. eCollection 2022.
2
Prevalence, symptom burden and under-diagnosis of chronic obstructive pulmonary disease in Polish lung cancer screening population: a cohort observational study.
BMJ Open. 2022 Apr 11;12(4):e055007. doi: 10.1136/bmjopen-2021-055007.
3
Lung Cancer Screening: Review and 2021 Update.
Curr Pulmonol Rep. 2022;11(1):15-28. doi: 10.1007/s13665-021-00283-1. Epub 2022 Apr 2.
4
An Update on the Use of Exhaled Breath Analysis for the Early Detection of Lung Cancer.
Lung Cancer (Auckl). 2021 Aug 16;12:81-92. doi: 10.2147/LCTT.S320493. eCollection 2021.
5
Diagnostic and prognostic value of microRNA-2355-3p and contribution to the progression in lung adenocarcinoma.
Bioengineered. 2021 Dec;12(1):4747-4756. doi: 10.1080/21655979.2021.1952367.
6
Differences in lung cancer characteristics and mortality rate between screened and non-screened cohorts.
Sci Rep. 2019 Dec 18;9(1):19386. doi: 10.1038/s41598-019-56025-6.
7
Low-dose CT examination for rib fracture evaluation: A pilot study.
Medicine (Baltimore). 2018 Jul;97(30):e11624. doi: 10.1097/MD.0000000000011624.
8
New recommendation and coverage of low-dose computed tomography for lung cancer screening: uptake has increased but is still low.
BMC Health Serv Res. 2018 Jul 5;18(1):525. doi: 10.1186/s12913-018-3338-9.
本文引用的文献
1
Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial.
Thorax. 2017 Oct;72(10):912-918. doi: 10.1136/thoraxjnl-2016-209690. Epub 2017 Jul 14.
2
Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.
PLoS Med. 2017 Apr 4;14(4):e1002277. doi: 10.1371/journal.pmed.1002277. eCollection 2017 Apr.
3
Risk stratification based on screening history: the NELSON lung cancer screening study.
Thorax. 2017 Sep;72(9):819-824. doi: 10.1136/thoraxjnl-2016-209892. Epub 2017 Mar 30.
4
Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.
PLoS Med. 2017 Feb 7;14(2):e1002225. doi: 10.1371/journal.pmed.1002225. eCollection 2017 Feb.
5
Comparing the performance of trained radiographers against experienced radiologists in the UK lung cancer screening (UKLS) trial.
Br J Radiol. 2016 Oct;89(1066):20160301. doi: 10.1259/bjr.20160301. Epub 2016 Jul 27.
6
Attitudes towards lung cancer screening in socioeconomically deprived and heavy smoking communities: informing screening communication.
Health Expect. 2017 Aug;20(4):563-573. doi: 10.1111/hex.12481. Epub 2016 Jul 11.
7
Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval.
Thorax. 2017 Jan;72(1):48-56. doi: 10.1136/thoraxjnl-2016-208655. Epub 2016 Jun 30.
8
Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
Lancet Oncol. 2016 Jul;17(7):907-916. doi: 10.1016/S1470-2045(16)30069-9. Epub 2016 Jun 6.
9
The Lung Screen Uptake Trial (LSUT): protocol for a randomised controlled demonstration lung cancer screening pilot testing a targeted invitation strategy for high risk and 'hard-to-reach' patients.
BMC Cancer. 2016 Apr 20;16:281. doi: 10.1186/s12885-016-2316-z.
10
Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.
Lancet Oncol. 2016 May;17(5):590-9. doi: 10.1016/S1470-2045(15)00621-X. Epub 2016 Mar 18.
Zotero 插件